Lone D.
- Country
- Denmark
- Department
- Oncology
Research Overview
- Neoadjuvant Pembrolizumab for Stage I-III dMMR Colon Cancer: A Phase II Organ-Sparing Study
- Phase III Randomized Study of Trifluridine/Tipiracil and Bevacizumab Versus Capecitabine and Bevacizumab in Metastatic Colorectal Cancer Unfit for Intensive Therapy
- Phase II Randomized Study of Gemcitabine Versus Reduced-Dose Gemcitabine and Paclitaxel Albumin-Bound in Frail Patients with Unresectable Pancreatic Cancer
Data & Insights
Has run more than one trial at 5 of 17 partner sites.
Specializations
Colorectal Cancer Research
This investigator specializes in treating metastatic colorectal cancer, with particular emphasis on developing therapeutic strategies for patients who require specialized treatment approaches.
- Advanced Stage Treatment Protocols
- First-line Therapeutic Strategies
- Targeted Biological Therapies
The investigator's work includes evaluation of treatment options for patients with MSI-High (Microsatellite Instability-High) and dMMR (Mismatch Repair Deficient) colorectal cancers.
Pancreatic Oncology
The investigator focuses on developing treatment approaches for non-resectable pancreatic cancer, particularly addressing the needs of fragile patients who require modified treatment protocols.
- Adaptive Chemotherapy Protocols
- Patient-Specific Treatment Optimization
- Modified Dosing Strategies
Special attention is given to evaluating treatment efficacy in patients who may not be candidates for standard intensive therapies.
Specialized Treatment Approaches
The investigator has developed expertise in personalized treatment strategies for cancer patients requiring modified therapeutic approaches.
- Alternative Treatment Protocols
- Combination Therapy Assessment
- Treatment Response Evaluation
Focus includes developing therapeutic solutions for patients who cannot undergo conventional intensive treatments.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.